Aurobindo Pharma, a mid-size pharmaceutical company, Aurobindo Pharma witnessed a fall in share price on Wednesday after the board of directors of the company, has considered and approved raising of the funds by the company through issue of securities upto an amount of USD 350 million or rupee equivalent thereof through follow on offer, qualified institutions placement, further public offer and / or private placement or by such other method subject to approval of the shareholders.

Shares of the company are trading at Rs 1,088.15, down Rs 22.3, or 2.01%  at the Bombay Stock Exchange (BSE) on Wednesday at 2:10 p.m.

The scrip has touched an intra-day high of Rs 1,112.00 and low of Rs 1,074.05. The total volume of shares traded at the BSE is 74,013.